Summer Fun and Science: The Exciting Return of the CBR Amazing Race
After a five-year hiatus, the CBR Amazing Race returned! Under the slogan “Summer Students Run. CBR Members Host”, nine CBR labs on campus united to host a one-of-a-kind science gaming event last Thursday afternoon.
Three CBR scientists awarded CIHR project grants
Congratulations to Dr. Jayachandran Kizhakkedathu, Dr. Kelly McNagny & Dr. Leonard Foster! UBC Medicine researchers awarded more than $25 million in CIHR project grants.
Transforming Transfusion: engineered platelets using lipid nanoparticles
A new exciting avenue of transfusion research is being investigated by the Kastrup, Cullis, Jan, and Devine labs at the CBR. They delve into the possibility of genetically modifying platelets to express proteins that may offer greater therapeutic benefits.
Antibiotic Failure – Beyond Antimicrobial Resistance
A recent review by the Hancock Lab delves into antimicrobial resistance, with topics that include contributors to antibiotic failure, how these may be alleviated by rapid diagnostics, and alternatives to antibiotics.
CBR Graduate Profile – Marie-Soleil Smith
Marie-Soleil Smith is a recent PhD graduate in Dr. Hélène Côté’s lab. We’re excited to share her journey at the CBR & wish her all the best in her next chapter.
Federal funding boosts 25 UBC Faculty of Medicine research projects including one CBR scientist
Congratulations to Dr. Jayachandran Kizhakkedathu! His project is one of 25 Faculty of Medicine research projects who are receiving federal funding from the NSERC Discovery Research Program.
Norman Bethune Symposium 2024 – Celebrating Drs. Don Brooks & Dana Devine
On April 18th, we held our 12th annual Norman Bethune Symposium, a renowned research event that gathers scientists, clinicians, healthcare professionals, and trainees to discuss advancements in the field of blood research.
Two CBR scientists are part of the interdisciplinary UBC team to train a new generation of immunoengineers
An interdisciplinary UBC team led by Dr. Peter Zandstra has received $1.65 million in federal funding to train a new generation of immunoengineers to innovate, develop and deliver new immunoengineering technologies for commercialization.
Jefferies lab demonstrates potential of a novel cell-based immunotherapy for cancer
A new study from the Jefferies lab highlights a promising, novel avenue for cancer immunotherapy using Type 2 innate lymphoid cells.
Welcome 2024 Summer Students!
We are so excited to welcome 20 summer students to this year’s CBR-LSI Summer Studentship Program. Over the next four months, these students will take part in exciting workshops alongside their research projects.